Cargando…

HLA Association with Drug-Induced Adverse Reactions

Adverse drug reactions (ADRs) remain a common and major problem in healthcare. Severe cutaneous adverse drug reactions (SCARs), such as Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) with mortality rate ranges from 10% to more than 30%, can be life threatening. A number of recent st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Wen-Lang, Shiao, Meng-Shin, Hui, Rosaline Chung-Yee, Su, Shih-Chi, Wang, Chuang-Wei, Chang, Ya-Ching, Chung, Wen-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733150/ https://www.ncbi.nlm.nih.gov/pubmed/29333460 http://dx.doi.org/10.1155/2017/3186328

Ejemplares similares

Associations of HLA-A and HLA-B with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population
por: Wang, Chuang-Wei, et al.
Publicado: (2022)

HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review
por: Cheng, Chi-Yuan, et al.
Publicado: (2014)

Digging Up the Human Genome: Current Progress in Deciphering Adverse Drug Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment
por: Lin, Yin-Ku, et al.
Publicado: (2022)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies
por: Ng, Chau Yee, et al.
Publicado: (2018)

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
por: Dao, Ro-Lan, et al.
Publicado: (2015)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review
por: Wang, Ching-Ya, et al.
Publicado: (2023)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
por: Wang, Chuang-Wei, et al.
Publicado: (2022)

Adverse Medication Reactions
por: Dodiuk-Gad, Roni P., et al.
Publicado: (2017)

A web resource for mining HLA associations with adverse drug reactions: HLA-ADR
por: Ghattaoraya, Gurpreet S., et al.
Publicado: (2016)

Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity
por: Jiang, Haiqin, et al.
Publicado: (2022)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs
por: Zhang, Jingang, et al.
Publicado: (2018)

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
por: Ko, Tai-Ming, et al.
Publicado: (2015)

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
por: Yu, Ya-Yen, et al.
Publicado: (2019)

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
por: Koomdee, Napatrupron, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
por: Satapornpong, Patompong, et al.
Publicado: (2021)

HLA-A*24:02 as a common risk factor for antiepileptic drug–induced cutaneous adverse reactions
por: Shi, Yi-Wu, et al.
Publicado: (2017)

An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese
por: Jiang, Menglin, et al.
Publicado: (2023)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines
por: Wang, Chuang-Wei, et al.
Publicado: (2023)

Predominant HLA Alleles and Haplotypes in Mild Adverse Drug Reactions Caused by Allopurinol in Vietnamese Patients with Gout
por: Van Son, Chu, et al.
Publicado: (2021)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
por: González-Galarza, Faviel F., et al.
Publicado: (2014)

Caveolin-1 Provides Palliation for Adverse Hepatic Reactions in Hypercholesterolemic Rabbits
por: Chen, Ya-Hui, et al.
Publicado: (2014)

Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions
por: Ramsbottom, Kerry A., et al.
Publicado: (2018)

High Diversity of Fusarium Species in Onychomycosis: Clinical Presentations, Molecular Identification, and Antifungal Susceptibility
por: Lu, Lai-Ying, et al.
Publicado: (2023)

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
por: Wu, Ran, et al.
Publicado: (2016)

HLA class I-drug-T-cell receptor interactions in SJS/TEN
por: Rive, Craig, et al.
Publicado: (2014)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review
por: Chen, Chun-Bing, et al.
Publicado: (2023)

Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test
por: Kim, Eun-Young, et al.
Publicado: (2019)

Optimal Frailty Dimensions for Assessing Frailty and Predicting Chemotherapy Adverse Events in Older Taiwanese Cancer Patients
por: Ho, Ya-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7g7op9jpna4cvr0qrinbcvr691